CINECA IRIS Institutional Research Information System

SALVETTI, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.159
EU - Europa 1.070
AS - Asia 1.040
SA - Sud America 94
Continente sconosciuto - Info sul continente non disponibili 76
AF - Africa 28
OC - Oceania 1
Totale 4.468
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.103
SG - Singapore 464
CN - Cina 295
IT - Italia 293
DE - Germania 151
VN - Vietnam 117
IE - Irlanda 100
FI - Finlandia 95
SE - Svezia 95
FR - Francia 74
BR - Brasile 66
AT - Austria 63
DK - Danimarca 50
UA - Ucraina 46
HK - Hong Kong 42
IN - India 29
JP - Giappone 29
GB - Regno Unito 28
CA - Canada 25
AR - Argentina 15
BE - Belgio 14
BY - Bielorussia 13
CH - Svizzera 11
MX - Messico 11
BD - Bangladesh 8
ID - Indonesia 8
KR - Corea 8
NL - Olanda 8
ZA - Sudafrica 8
ES - Italia 7
IQ - Iraq 7
JM - Giamaica 7
RU - Federazione Russa 7
CR - Costa Rica 6
SN - Senegal 6
PL - Polonia 5
TH - Thailandia 5
TR - Turchia 4
UZ - Uzbekistan 4
VE - Venezuela 4
EC - Ecuador 3
EG - Egitto 3
JO - Giordania 3
MA - Marocco 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AZ - Azerbaigian 2
CO - Colombia 2
EU - Europa 2
KE - Kenya 2
LT - Lituania 2
NI - Nicaragua 2
PK - Pakistan 2
PY - Paraguay 2
RO - Romania 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
YE - Yemen 2
AL - Albania 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CI - Costa d'Avorio 1
CL - Cile 1
EE - Estonia 1
ET - Etiopia 1
GP - Guadalupe 1
GR - Grecia 1
HR - Croazia 1
IL - Israele 1
LB - Libano 1
ML - Mali 1
MW - Malawi 1
MY - Malesia 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
TG - Togo 1
TN - Tunisia 1
VC - Saint Vincent e Grenadine 1
Totale 4.394
Salva come PNG Salva come JPEG
Città #
Chandler 300
Singapore 274
San Jose 173
Santa Clara 170
Beijing 154
Ashburn 140
Munich 102
Dublin 99
Ann Arbor 90
Helsinki 74
Vienna 58
Dearborn 51
Nyköping 49
Torino 48
Wilmington 44
The Dalles 42
Fairfield 41
Council Bluffs 40
Los Angeles 39
Dallas 38
Houston 36
Medford 34
Hong Kong 33
Jacksonville 33
Turin 30
Milan 29
Princeton 28
Tokyo 28
Columbus 27
Woodbridge 27
Hanoi 26
Ho Chi Minh City 23
Fremont 22
Lauterbourg 22
Seattle 20
Rome 19
San Mateo 18
Guangzhou 17
New York 17
Cambridge 15
Hangzhou 14
Brussels 13
Chennai 13
Dong Ket 12
São Paulo 12
Redwood City 10
Linden 9
Buffalo 8
Chengdu 8
Hefei 8
Jyväskylä 8
Oerlikon 8
Orem 8
Falkenstein 7
Naples 7
San Diego 7
Seoul 7
Turku 7
Atlanta 6
Codogno 6
Denver 6
Falls Church 6
Haiphong 6
Maple Grove 6
Memphis 6
Montreal 6
Poplar 6
Redondo Beach 6
Wayne 6
Belo Horizonte 5
Biên Hòa 5
Bologna 5
Bắc Ninh 5
Casorzo 5
Central District 5
Chicago 5
Da Nang 5
Guiyang 5
Indianapolis 5
Jakarta 5
Mexico City 5
Nanjing 5
Villeurbanne 5
Washington 5
Canelli 4
Cape Town 4
Duncan 4
Hyderabad 4
Johannesburg 4
London 4
Miami 4
Norwalk 4
Phoenix 4
Piemonte 4
Pisa 4
Salt Lake City 4
San José 4
Shanghai 4
Toronto 4
Balingen 3
Totale 2.900
Salva come PNG Salva come JPEG
Nome #
REGULATION OF HIF-1 alpha IN TP53 DISRUPTED CHRONIC LYMPHOCYTIC LEUKEMIA CELLS AND ITS POTENTIAL ROLE AS A THERAPEUTIC TARGET 365
Regulation of HIF-1α in TP53 disrupted chronic lymphocytic leukemia cells and its potential role as a therapeutic target 256
HIF-1α is overexpressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia 236
Magic pills: new oral drugs to treat chronic lymphocytic leukemia 229
Autoimmune complications in chronic lymphocytic leukemia in the era of targeted drugs 203
Regulation of HIF-1α in TP53 Disrupted Chronic Lymphocytic Leukemia Cells and Its Potential Role as a Therapeutic Target 195
Abstract 2072: Selinexor in combination with chemotherapy or idelalisib elicits a synergistic cytotoxic effect in primary CLL cells 175
Pre-existing and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs 171
Targeting hif-1α regulatory pathways as a strategy to hamper tumor-microenvironment interactions in cll 171
ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems 168
Selinexor in Combination with Chemotherapy or Idelalisib Elicits a Synergistic Cytotoxic Effect in Primary CLL Cells, Also Overcoming Intrinsic and Stromal Cells-Mediated Fludarabine Resistance 166
Modulation of Phenotypic and Functional Features of Immune Cells in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib 161
SELINEXOR (KPT-330) IN COMBINATION WITH CHEMOTHERAPY OR IDELALISIB ELICITS A SYNERGISTIC CYTOTOXIC EFFECT IN PRIMARY CLL CELLS, ALSO OVERCOMING INTRINSIC AND STROMAL CELLS-MEDIATED FLUDARABINE RESISTANCE 158
Idelalisib nei pazienti con leucemia linfatica cronica e linfoma follicolare: esperienza monocentrica real life 158
Immune dysfunctions and immune-based therapeutic interventions in chronic lymphocytic leukemia 154
Ibrutinib Treatment Mitigates Phenotypic Alterations of Non-Neoplastic Immune Cell Compartments in Chronic Lymphocytic Leukemia 146
Evaluation of the cytotoxic effect of selinexor in combination with chemotherapy or idelalisib towards primary CLL cells 143
TARGETING THE CXCR4 DOWNSTREAM SIGNALLING PATHWAYS TO REVERSE MICROENVIRONMENT PROTECTION IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS 141
Regulation of HIF-1α in TP53 disrupted chronic lymphocytic leukemia cells and its potential role as a therapeutic target 135
Pre-Existing and Treatment-Emergent Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Drugs 134
The CXCR4 downstream signaling pathways in chronic lymphocytic leukemia: a target to reverse microenvironment protection 133
TARGETING HIF-1A AND ITS REGULATORY PATHWAYS AS A STRATEGY TO HAMPER LEUKEMIA-MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 126
Ibrutinib Treatment Mitigates Phenotypic Alterations of Non-Neoplastic Immune Cell Compartments in Chronic Lymphocytic Leukemia 121
TARGETING HIF-1 AND ITS REGULATORY PATHWAYS AS A STRATEGY TO HAMPER TUMOR-MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 115
Refractory and 17p-deleted chronic lymphocytic leukemia: improving survival with pathway inhibitors and allogeneic stem cell transplantation 111
Sequential Development of Three Mature Lymphoid Neoplasms in a Single Patient: Clonal Relationship and Molecular Insights 99
Selinexor in Combination with Chemotherapy or Idelalisib Elicits a Synergistic Cytotoxic Effect in Primary CLL Cells 98
Totale 4.468
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.671
article - articoli 0
book - libri 0
conference - conferenze 8.684
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.355
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022371 0 0 19 24 30 8 31 19 11 30 119 80
2022/2023615 70 71 28 63 54 137 34 41 58 25 22 12
2023/2024174 26 39 7 10 7 29 5 6 4 12 9 20
2024/2025835 1 5 32 68 219 89 80 74 114 29 42 82
2025/20261.327 117 51 81 132 186 53 244 24 122 94 59 164
2026/2027142 49 54 39 0 0 0 0 0 0 0 0 0
Totale 4.468